动脉关闭方面的进展:使用Celt ACD装置的新型关闭策略
Benjamin Daniel1, James Griggers2, Brian Kouri1
1Department of Radiology, Wake Forest School of Medicine, Winston Salem, NC, USA.
The journal of vascular access
|November 11, 2025
概括
凯尔特人动脉关闭装置 (ACD) 在两个复杂的非大腿动脉接入部位成功实现了静血. 这种钢塞系统的多功能性超出了传统的股骨用于血管通道关闭的范围.
科学领域:
- 血管外科 血管外科
- 干预心脏病学 干预心脏病学
- 医疗器械技术 医疗器械技术
背景情况:
- 凯尔特动脉关闭装置 (ACD) 是一个钢塞系统,用于动脉接入部位静血.
- 虽然通常用于关动脉接入,但其设计表明非传统网站的潜力.
研究的目的:
- 评估Celt动脉关闭装置 (ACD) 在非股骨动脉接入部位的有效性和安全性.
- 评估设备在解剖学上复杂的血管接入位置上的性能.
主要方法:
- 在一个单一中心对3609个凯尔特人ACD病例 (2020-2024) 进行了回顾性审查.
- 确定并分析了两个涉及非大腿关动脉接入的病例.
主要成果:
- 凯尔特人ACD用于两个非大腿部接入点:内动脉和胸前动脉.
- 在这两种情况下都成功实现了血液静止,在手术后的7个月和1个月分别观察到设备的稳定位置.
结论:
- 凯尔特动脉关闭装置 (ACD) 在复杂的非大腿动脉接入部位中有效实现静血.
- 该设备在超出标准的股骨使用范围的具有挑战性的解剖位置中展示了多功能性和安全性.
相关概念视频
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...


